• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Protection from SARS-CoV-2 re-infection may be diminished among elderly individuals

byCyrus AyubchaandTeddy Guo
April 12, 2021
in Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Prior infection with SARS-CoV-2 in the first wave (i.e. before June 2020) was linked to significant protection against reinfection in the second wave in the general population.

2. Protection from repeat SARS-CoV-2 infection was relatively weaker in older populations.

Evidence Rating Level: 2 (Good)

Study Rundown: Little is known about the protective immunity from SARS-CoV-2 repeat infections after an initial positive infection. In this population-level observational study, PCR testing records of those infected with SARS-CoV-2 during the first surge were tracked through to the second surge in Denmark. Infection rates during the second surge were compared among individuals with positive and negative PCR tests during the first surge. Analyses found that those who tested positive during the first surge were significantly less likely to have tested positive during the second surge compared to those who tested negative during the first surge. This protective effect was observed weakly in older populations where the likelihood of testing positive upon previous infection was notably higher compared to younger cohorts. There were no observed differences between sexes or the time between first infection and reinfection. This study is strengthened by its large subject pool and natural setting; this inclines the study to apply to practical public health settings. Limitations include the observational nature where one must assume similar characteristics (e.g., health behaviors, the likelihood of acquiring or seeking testing, exposure risk) among between groups and within groups over time; in other words, this study suggested but did not prove that prior infection directly prevented reinfection.

Click to read the study in The Lancet

Relevant Reading: What we know about covid-19 reinfection so far

In-Depth [retrospective cohort]: This study utilized a national surveillance dataset to access the SARS-CoV-2 PCR testing records of all those tested in Denmark between February 26th and December 21st, 2020. Only those tested during both the first and second surges were included in further analysis. The first surge was considered to be the period before June 2020, while the second surge was between Sept 1, 2020-Dec 31, 2020. Adjusted rate ratios with 95% CI intervals were derived from a Poisson regression as adjusted for sex, age group. The positivity rates were 2.20% (11 727 of 533 381) and 4.32% (150 159 of ~3 480 000) for the first and second surges, respectively. During the second surge, daily rates of infection were 5.35 positive tests per 100 000 people for those who previously tested positive in the first surge compared to 27.06 positive tests per 100 000 people for those who tested negative in the first surge. The adjusted relative risk of infection in the second surge was 0.195 (95% CI 0.155 – 0.246) when comparing those with a prior positive test to those with a negative test during the first surge. The overall protective effect against repeat infection was determined to be 78.8% (95% CI 74.9–82.1). The sub-analysis of those above the ages of 65 indicated a protective effect of only 47.1% (24.7–62.8) whereas all other younger cohorts reached levels above 80% (p <0.0001).

RELATED REPORTS

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

BNT162b2 safe and efficacious in children 5 to 11 years of age

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: covidcovid-19 infectionCOVID-19 reinfectionreinfectionreinfection riskSARS-CoV-2
Previous Post

#VisualAbstract: Major postoperative complications are associated with worse long-term survival in patients undergoing esophagectomy

Next Post

Post-COVID syndrome associated with significant morbidity and mortality beyond respiratory illnesses

RelatedReports

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

May 13, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

May 13, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

BNT162b2 safe and efficacious in children 5 to 11 years of age

May 13, 2022
Masks for personal protection for SARS-CoV-2 infection
Chronic Disease

Adding mask recommendation did not significantly reduce the SARS-CoV-2 infection rate

May 13, 2022
Next Post
Hydroxychloroquine not beneficial for early, mild COVID-19

Post-COVID syndrome associated with significant morbidity and mortality beyond respiratory illnesses

#VisualAbstract Rituximab plus high-dose chemotherapy (MegaCHOEP) show similar long-term efficacy to conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma

#VisualAbstract Rituximab plus high-dose chemotherapy (MegaCHOEP) show similar long-term efficacy to conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma

History of recurrent spontaneous abortions linked to increased risk of premature mortality

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
  • #VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly
  • Wellness Check: Sleep
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.